Funding
Funding a Hong Kong-Shenzhen R&D Collaboration
Compare Hong Kong-Shenzhen R&D funding routes: who applies, who receives the grant, company contributions and rights to the research results.
Listen to the audio analysis
Create your ownWritten for builders and creators.
When you are structuring a research partnership, one of the first practical questions you have to answer is whether your organization will be the one applying for the funds or if you will simply be using the results later.
You can seek public support for research shared between Hong Kong and Shenzhen, but your company may be the research partner rather than the grant applicant. That changes who receives the money, what your business contributes and whether it owns the technology it hopes to sell.
This guide explains 2 institutional routes, Shenzhen's Category C basic research programme and Hong Kong's Mainland-Hong Kong Technology Cooperation Funding Scheme. It also shows when a direct company R&D application is a more relevant starting point. If you're a founder considering a university or R&D-centre collaboration, these are the funding arrangements to settle before treating the project as financed.
Hong Kong dollars and renminbi remain separate. Programme research is from 2-4 November 2026, with selected Hong Kong sources rechecked on 10 November and the collaboration notices checked on 18 November. Signed project agreements and some municipal source documents remain unavailable.
Choose the Applicant Before the Funding Amount
| Route | Who Applies | Who Receives the Grant | What It Means for Your Company |
|---|---|---|---|
| Shenzhen-Hong Kong-Macao Category C basic research | An eligible Hong Kong research institution/R&D centre or named Macao institution | The Hong Kong or Macao applicant | A Shenzhen company participates as a partner. The institution owns the resulting IP under the published guide. |
| Mainland-Hong Kong Technology Cooperation Funding Scheme | An eligible Hong Kong institutional lead and an eligible Mainland applicant, each filing locally | Each authority pays its own applicant | Industry sponsorship is required. A qualifying Hong Kong industry co-applicant normally contributes at least half the project cost and can own project IP. |
| Hong Kong Enterprise Support Scheme | An eligible Hong Kong company conducting its own R&D | The recipient company | A 1:1 matched company project, with company IP ownership. Overseas collaboration or spending still needs to fit its approved scope. |
The first 2 routes organise a funded research collaboration. ESS funds an eligible company's own R&D. A Shenzhen company looking for its own municipal award should use the Shenzhen funding guide, where applicant and spending tests are different again.
Shenzhen Category C: An Institution-Led Project With Shenzhen Commercialisation
The announced 2026 Category C application window runs from 23 November to 31 December 2026, closing at 16:00 China Standard Time. The notice and linked application guide concern basic research involving eligible Hong Kong or Macao institutions.
Support can reach RMB3 million per project, no more than the amount requested, with at most 20 projects supported. Those are programme limits, not a forecast of an individual award.
Your Research Partner Must Be an Eligible Applicant
The Hong Kong applicant categories include UGC-funded universities, specified self-financing degree institutions, named public research bodies and R&D centres established under Hong Kong's Innovation and Technology Fund. The Macao side lists specific institutions.
A Hong Kong private company is not eligible merely because it conducts research. A Shenzhen company can join as a partner, but that does not make it the applicant or recipient of the whole grant.
The guide generally provides for a 2-year project. Research equipment bought with the Shenzhen funding and the resulting intellectual property belong to the Hong Kong or Macao applicant. Industrialisation of the results is to take place in Shenzhen.
For a startup, that makes the commercial agreement important early. If your business needs a licence or other rights to sell the research outcome, identify those rights with the institution before assuming the grant gives them to the company. The institution's ownership and your company's commercial access are separate questions.
Match the Partner Budget to the Actual Money Received
The guide requires a company partner's own contribution to be at least the fiscal funding that company receives. That is a test on the company's allocation, not a claim that every partner must match the entire RMB3 million headline ceiling.
For example, if an approved arrangement allocates RMB400,000 of fiscal funding to a company partner, the published test requires at least RMB400,000 of that company's own contribution. This is an illustrative application of the rule. It does not establish that any proposed allocation or expense will be accepted.
The same research content cannot also receive other government fiscal funding under this route. A second funding programme on the other side of the border is therefore not automatically another source of money for the same work.
Payment and Completion Still Matter
The actual 2026 guide describes 60% paid initially and up to 40% after the completion audit, with the final amount constrained by accepted actual expenditure. The initial recipient is the institution. Your company's receipt, if any, must follow the approved partner arrangement.
An expired earlier rule used different percentages. Its republication on a newer web page does not make it the governing rule for this call.
Current municipal funding and acceptance rules also attach reporting, audit and recovery obligations. The precise outcome depends on whether a project is completed, terminated, cancelled or found non-compliant. The available material does not establish a single harmless exit or universal repayment amount. Read the applicable task agreement before committing your company's contribution.
Hong Kong MHKTCFS: Joint Research With a Local Institutional Lead
The Mainland-Hong Kong Technology Cooperation Funding Scheme, or MHKTCFS, supports work conducted in both Hong Kong and the Mainland. It includes jointly solicited projects with national, Guangdong and Shenzhen authorities.
The particular solicitation matters. A project involving Shenzhen must fit the relevant call and partner arrangements. The scheme name does not mean any Hong Kong-Shenzhen project has a standing entitlement to funding.
Hong Kong's window for the Guangdong and Shenzhen rounds is 12 October to 11 December 2026. For the Shenzhen round, the Category A municipal notice gives a separate filing deadline of 27 November 2026 at 18:00 local time. An eligible Shenzhen company or research institution can lead the Shenzhen application. The national Ministry of Science and Technology round is announced separately. Use the Hong Kong application system and the relevant calls for the topics and submission requirements.
Both sides must submit to their respective authorities simultaneously. Plan the joint filing around the earlier deadline. Each side vets its own application and both must approve the project. Shenzhen Category C has a separate application and window.
Platform and Collaborative Projects Ask Different Things of Industry
The official programme summary distinguishes:
- Platform projects: industry sponsorship of at least 10% of project cost, supporting research with wider industry relevance.
- Collaborative projects: an eligible industry co-applicant normally sponsors at least 50% of project cost and can own the project IP, subject to the agreement between the parties.
That industry co-applicant must be a Hong Kong-incorporated company or another specified eligible industry body. A Shenzhen-only company does not meet this Hong Kong co-applicant test. The Mainland applicant or partner is a separate role in the bilateral arrangement.
At least half the minimum industry sponsorship must be cash. Accepted in-kind sponsorship is limited to specified equipment and consumables, with staff support treated separately. A founder should not assume the team's existing salaries satisfy the cash requirement. The October 2026 application guide sets out the calculation.
There is a narrower exception for specially approved R&D-centre collaborative projects with sponsorship between 30% and 49.99%. In that case, the research lead retains IP ownership. This is an approval-dependent arrangement, rather than the standard company co-applicant route.
Platform projects' lower sponsorship percentage is not a discounted route to the same exclusive rights. The successful-applicant guide expects platform results to be made available on open, transparent and non-exclusive terms. A company requiring exclusive commercial control has a different discussion from a sponsor helping develop a technology the wider industry can adopt.
Divide the Work and Spending Before Applying
MHKTCFS requires work in both places, with most R&D carried out in Hong Kong. The current application guide permits up to 50% of R&D work and related expenditure in the Mainland. Its June 2025 successful-applicant guide also generally limits Mainland spending to 50% of approved total project cost, net of overheads. Other overseas R&D work requires prior approval with justification. The actual project agreement and applicable call remain important.
The Hong Kong lead and Mainland research partner, plus the industry co-applicant where applicable, need a credible division of research tasks and spending. The guide limits particular manpower, equipment and other costs, and requires approved changes when the project departs materially from its agreed scope.
Each Authority Pays Its Own Applicant
Hong Kong's Innovation and Technology Commission releases its funding to the Hong Kong institutional lead in instalments. Payment depends on required contributions and satisfactory progress. The Shenzhen authority pays the Shenzhen applicant separately and monitors that side under its own terms. A company joining as a Hong Kong industry co-applicant should budget its sponsorship separately from the grant paid to the institutional lead. ITF scheme rules
The guide also requires annual and/or final independent audited accounts. Misspent amounts can be recovered with interest, and residual funding must be returned under the agreement's applicable proportions. An application charging no fee would not remove the audit or project-delivery costs.
When a Direct Company R&D Route Makes More Sense
If your Hong Kong company has the people and capability to conduct the R&D itself, ESS may be a better route to investigate than searching for an institutional lead solely to access a grant.
It offers 1:1 matching support up to HK$10 million, generally for projects of up to 24 months. The recipient company owns the project IP. Applications are accepted year-round, subject to the eligibility and assessment process.
An overseas partner does not automatically make all cross-border expenditure eligible. Set out what your company does, what any partner does and where the expenditure occurs, then use ESS's own approved budget and conditions. MHKTCFS's Mainland-spending allowance should not be transferred into an ESS budget.
For a Shenzhen company, municipal R&D support is another separate assessment. A cross-border collaborator and an in-house R&D grant can both be useful, but their applicant, cost and duplication rules determine whether they fit your project.
Put the Partnership Terms Into the Funding Plan
Before treating a collaboration as a financing option, the partners need agreement on:
- Application and approvals: the lead applicant, each authority's submission and any conditions linking the approvals.
- Work and money: which team performs each task, where costs arise, who pays first and which account receives funding.
- Commercial rights: existing IP brought into the project, ownership of new results and the company's rights to use or license them.
- Delivery obligations: milestones, records, audits, changes, completion and the consequences if a partner withdraws.
The grant-budgeting companion explains the payment-calendar calculation. For a collaboration, make that calendar partner by partner. Money awarded to an institution and money available to your company's payroll are different entries.
A useful funded partnership joins research capability to a commercial plan. Choose the route whose applicant, work split and ownership terms support that plan. The application then describes a collaboration the partners can deliver, rather than leaving them to negotiate the business after the award.